title: Treating Graves' orbitopathy: where are we?
authors.forename: Maria Laura
authors.initials: ML
authors.lastname: Tanda
authors.forename: Eliana
authors.initials: E
authors.lastname: Piantanida
authors.forename: Luigi
authors.initials: L
authors.lastname: Bartalena
mesh_terms: D052438:Adipocytes, White / Q000187:drug effects*; D050156:Adipogenesis / Q000187:drug effects*; D000818:Animals; D013956:Antithyroid Agents / Q000627:therapeutic use*; D015536:Down-Regulation / Q000187:drug effects*; D005260:Female; D049970:Graves Ophthalmopathy / Q000188:drug therapy* / Q000532:radiotherapy* / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D013792:Thalidomide / Q000494:pharmacology*; D013965:Thyroidectomy
chemical_list: D013956:Antithyroid Agents; D007166:Immunosuppressive Agents; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D013792:Thalidomide